✦ LIBER ✦

Anatomical basis of intra-arterial chemotherapy for patients with locally advanced breast cancer

✍ Scribed by Ms J. C. Doughty; D. H. A. McCarter; E. Kane; A. W. Reid; T. G. Cooke; C. S. McArdle

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 306 KB
Volume: 83
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800830830

No coin nor oath required. For personal study only.

✦ Synopsis

Twenty-eight patients with locally advanced breast cancer per cent. In 33 per cent of patients the lateral thoracic received four doses of regional chemotherapy via artery did not contribute to breast perfusion and a large angiographically placed percutaneous catheters into the area of the lateral aspect of the breast was perfused from internal mammary artery (IMA) and lateral thoracic a further branch of the subclavian or axillary artery. The artery. Patent blue dye was injected to outline the relative blood supply to the breast is extremely variable and must contribution to perfusion of each of these vessels. The be determined in each patient before delivering regional IMA was found to perfuse 67 (range 20-95) per cent of chemotherapy. the breast and the lateral thoracic artery 15 (range 0-35)

📜 SIMILAR VOLUMES

Intra-arterial infusion chemotherapy as

Intra-arterial infusion chemotherapy as an induction therapy in multidisciplinary treatment for locally advanced breast cancer. A long-term follow-up study

✍ Hiroki Koyama; Yukio Nishizawa; Tomio Wada; Toshiyuki Kabuto; Eiichi Shiba; Take 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

Tolerance of half-body irradiation as sy

Tolerance of half-body irradiation as systemic therapy for patients with locally advanced breast cancer

✍ Gocheva, Lilia; Todorov, Jordan; Danon, Samuel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

Background.

A reappraisal of intra-arterial chemothe

A reappraisal of intra-arterial chemotherapy. Results obtained in 145 patients with head and neck cancer treated during 1963-1966 with intra-arterial chemotherapy followed by radical radiotherapy

✍ C. Nervi; G. Arcangeli; C. Casale; M. Cortese; A. Guadagni; V. Le Pera 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views

I strated49 5. 7, 10, 11 that protracted intraarterial Chemotherapy with cytotoxic agents is particularly effective in shrinking or causing transient complete regression in cancer. Rest results have been observed in head and neck, limb, and liver cancer, as the specific vascularization of these area

The treatment of locally advanced cancer

The treatment of locally advanced cancer of the head and neck with intra-arterial cytotoxics, cobalt, and hyperbaric oxygen therapy

✍ Professor R. Sealy; P. Helman; Anita Greenstein; B. Shepstone 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Monitoring the response of patients with

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography

✍ David A. Mankoff; Lisa K. Dunnwald; Julie R. Gralow; Georgiana K. Ellis; Mariann 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

## BACKGROUND. Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIBI) for monitoring the response of

Neoadjuvant chemotherapy for patients wi

Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma : Effect on tumor cell microinvolvement of regional lymph nodes

✍ Karen Becker; Umberto Fumagalli; James D. Mueller; Ulrich Fink; J. Rüdiger Siewe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

## BACKGROUND. In a previous study the authors demonstrated, using immunohistochemical methods for epithelial antigens, that the regional lymph nodes of gastric adenocarcinoma contained individual tumor cells or small clusters of these cells (tumor cell microinvolvement [TCM]) in over 90% of cases